Econazole Nitrate Cream Recalled Due to Manufacturing Process Deviations
Teligent Pharma is recalling Econazole Nitrate Cream, 1% due to current Good Manufacturing Practice deviations related to discontinued stability studies. Approximately 151,975 tubes distributed nationwide are affected.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The hazard is regulatory—discontinued stability studies creating uncertain product stability—not a confirmed contamination or defect. This falls within the low-risk, precautionary recall category.
Plain-English summary
Teligent Pharma, Inc. is recalling all lots of Econazole Nitrate Cream, 1% within their expiration dates due to current Good Manufacturing Practice (cGMP) deviations. The recall was initiated because the manufacturer discontinued its stability study program.
Econazole Nitrate Cream is a prescription antifungal medication supplied in three package sizes: 15-gram tubes (NDC 52565-022-15), 30-gram tubes (NDC 52565-022-30), and 85-gram tubes (NDC 52565-022-85). Approximately 151,975 tubes have been distributed nationwide in the United States and Puerto Rico.
The affected product includes batches with the following lot numbers and expiration dates: 16410, 16438 (expires 1/31/2023); 16882 (expires 4/30/2023); and 15349 (expires 2/28/2022). Patients should contact their healthcare provider or pharmacist for guidance regarding their current prescriptions.
The recalled product
- Product
- Econazole Nitrate Cream, 1%, packaged in a) 15 grams tubes, NDC 52565-022-15; b) 85 grams tubes, NDC 52565-022-85; c) 30 grams tubes, NDC 52565-022-30, Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, New Jersey 08310.
- Manufacturer
- Teligent Pharma, Inc.
- Category
- Drug — Topical Antifungal
- Hazard
- Affected units
- 151,975
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Batch: a) 16410
- 16438
- Exp. 1/31/2023
- 16882
- Exp. 4/30/2023
- b) 15349
- Exp. 2/28/2022
- 16410
- c) 16410
Distribution
Part of a larger recall action
This product is one of 37 recalled by Teligent Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · Teligent Pharma, Inc.
See all →- ModerateDesonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Cream USP 0.1% Recall — Stability Study Discontinuation
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- HighDiflorasone Diacetate Ointment recalled due to discontinued stability studies
FDA (Drugs) · 2022-03-30
- ModerateClobetasol Propionate Cream USP 0.05% Recall for cGMP Deviations
FDA (Drugs) · 2022-03-30
Same hazard · stability unverified
See all →- HighFluticasone Propionate Nasal Spray Recalled Due to Manufacturing Quality Concerns
FDA (Drugs) · 2023-06-07
- ModerateAkorn Recalls Cromolyn Sodium Ophthalmic Solution Over Stability Studies
FDA (Drugs) · 2023-06-07
- ModerateFerrous Sulfate Iron Supplement Drops Recalled for Manufacturing Stability Issues
FDA (Drugs) · 2023-06-07
- HighTrihexyphenidyl Hydrochloride Oral Solution Recalled for Unverified Stability
FDA (Drugs) · 2023-06-07
- HighNeomycin and Polymyxin B Eye Ointment Recalled for Incomplete Stability Studies
FDA (Drugs) · 2023-06-07